Predictive genomics: A cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data
arXiv:1408.2009 · doi:10.1016/j.semcancer.2014.04.002
Abstract
We discuss a cancer hallmark network framework for modelling genome-sequencing data to predict cancer clonal evolution and associated clinical phenotypes. Strategies of using this framework in conjunction with genome sequencing data in an attempt to predict personalized drug targets, drug resistance, and metastasis for a cancer patient, as well as cancer risks for a healthy individual are discussed. Accurate prediction of cancer clonal evolution and clinical phenotypes will have substantial impact on timely diagnosis, personalized management and prevention of cancer.
5 figs, related papers, visit lab homepage: http://www.cancer-systemsbiology.org, Seminar in Cancer Biology, 2014
References in corpus (4)
- Signaling Network Assessment of Mutations and Copy Number Variations Predicts Breast Cancer Subtype-specific Drug Targets
- Understanding genomic alterations in cancer genomes using an integrative network approach
- Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks
- Cancer systems biology in the genome sequencing era: Part 2, evolutionary dynamics of tumor clonal networks and drug resistance